Swedres-Svarm 2005

Total Page:16

File Type:pdf, Size:1020Kb

Swedres-Svarm 2005 SVARM Swedish Veterinary Antimicrobial Resistance Monitoring Preface .............................................................................................4 Summary ..........................................................................................6 Sammanfattning................................................................................7 Use of antimicrobials (SVARM 2005) .................................................8 Resistance in zoonotic bacteria ......................................................13 Salmonella ..........................................................................................................13 Campylobacter ...................................................................................................16 Resistance in indicator bacteria ......................................................18 Escherichia coli ...................................................................................................18 Enterococcus .....................................................................................................22 Resistance in animal pathogens ......................................................32 Pig ......................................................................................................................32 Cattle ..................................................................................................................33 Horse ..................................................................................................................36 Dog .....................................................................................................................37 Cat ......................................................................................................................39 Appendix 1: Demographic data .......................................................42 Appendix 2: Materials and methods, use of antimicrobials ..............44 Appendix 3: Materials and methods, resistance monitoring ............45 Appendix 4: Antimicrobial agents licensed ......................................49 Appendix 5: References ..................................................................50 © Statens Veterinärmedicinska Anstalt, National Veterinary Institute Uppsala, Sweden Printed by Edita Västra Aros, Västerås, Sweden ISSN Produced by SVA Graphic production by Björn Lundquist AB, Malmö, Sweden Photographs by Bengt Ekberg, SVA SVARM 2005 Swedish Veterinary Antimicrobial Resistance Monitoring Editors Björn Bengtsson, Christina Greko and Ulrika Grönlund-Andersson Department of Antibiotics, National Veterinary Institute (SVA) SE-751 89 Uppsala Sweden Authors Björn Bengtsson, Anders Franklin, Christina Greko and Ulrika Grönlund-Andersson Department of Antibiotics, SVA Kristina Odensvik Apoteket AB (National Corporation of Swedish Pharmacies) SVARM laboratory working group Maria Finn, Margareta Horn af Rantzien, Annica Landén, Verena Rehbinder and Susanna Thyselius Department of Antibiotics, SVA SVARM advisory committee Björn Bengtsson, Anders Franklin, Christina Greko and Ulrika Grönlund-Andersson, Department of Antibiotics, SVA Viveka Båverud, Department of Bacteriology, SVA Desirée Jansson, Department of Pigs, Poultry and Ruminants, SVA Ivar Vågsholm, Zoonosis Center, SVA Kristina Odensvik, Apoteket AB Text and tables may be cited and reprinted only with reference to this report Suggested citation: SVARM 2005, Swedish Veterinary Antimicrobial Resistance Monitoring. The National Veterinary Institute (SVA), Uppsala, Sweden, 2006. www. sva.se, ISSN 1650-6332. This report is available at www.sva.se Reprints can be ordered from Department of Antibiotics National Veterinary Institute SE-751 89 Uppsala Sweden Phone: +46 (0) 18 67 40 00 Fax: +46 (0) 18 30 91 62 e-mail: [email protected] S VA R M 2 0 0 5 3 Preface WELCOME to the fourth Swedish report combining results animal pathogens is thereby available for practitioners, facili- from the monitoring of antimicrobial resistance and anti- tating the therapeutic choice in the clinical setting. Moreover, microbial usage in both veterinary and human medicine: high-quality data allows appropriate analysis of trends in SVARM and SWEDRES. It is today generally accepted that resistance and of underlying causes for such trends and will all use of antimicrobials in different sectors contributes to be a most important complement to the data from indicator the development of resistance. This joint report will facilitate and zoonotic bacteria. SVARMpat is run in collaboration comparisons of resistance levels and incidence of use in the between the National Veterinary Institute (SVA) and the two areas. Swedish Animal Health Service (SvDHV) and is financed by In 2005, surveillance of antimicrobial resistance in animal the Swedish Board of Agriculture. pathogens in Sweden has been significantly broadened with According to the Zoonosis Directive that was adopted in the initiation of SVARMpat. The objective of SVARMpat is the EU in 2003, surveillance of antimicrobial resistance shall to improve the monitoring of pathogens in farm animals by not only comprise zoonotic organisms such as Salmonella active, targeted sampling and collection of high-quality data and Campylobacter but should also include indicator bacteria on antimicrobial resistance. Results will be reported yearly in such as Escherichia coli and enterococci from food animals the SVARM report. Updated knowledge on susceptibility of and food. The indicator bacteria constitute a reservoir of 4 S VA R M 2 0 0 5 resistance genes that may be transferred to pathogenic bacte- on unfavourable development of resistance indicate that the ria in animals and man. SVARM will in the near future also antimicrobial arsenal available is becoming more and more include zoonotic and indicator bacteria isolated from food limited. Further efforts must be made to prevent infectious of animal origin, according to a decision by the Swedish diseases both in human and in veterinary medicine by other Parliament in 2006. The programme will be initiated and means. organised in collaboration between SVA and the National Our hope is that this report will serve as a basis for policy Food Administration. recommendations and intervention strategies, and that it will Data in this report indicate, as also the data presented increase our understanding of the dynamics of resistance. The previously, that the Swedish strategies in human and veteri- ultimate goal is to preserve the effectiveness of available anti- nary medicine have been successful in containing resistance. microbials for man and animals. The general concept is to use antimicrobials only when needed, on prescription by a professional only, and that the choice of treatment is based on relevant information. Notwithstanding, some of the presented results in both veterinary and human fields are cause for concern. Examples S VA R M 2 0 0 5 5 Summary THE SIXTH REPOrt from SVARM shows that the situation Indicator bacteria, i.e. Escherichia coli and Enterococcus spp. regarding antimicrobial resistance in bacteria of animal origin from healthy animals, are monitored since resistance in the is stable. Resistance does occur but viewed from an interna- normal gut flora reflects the antimicrobial selective pressure in tional perspective the prevalence is low. Likewise, data in the an animal population. If harmonised methodology is used, data corresponding report covering human medicine, SWEDRES can be compared over time and on an international level. This (http://www.strama.org or http://www.smittskyddsinstitutet. year, indicator bacteria from healthy slaughter pigs were moni- se) indicate a favourable situation. tored. Levels of resistance are low in an international perspec- The total amount of antimicrobials used for animals tive and have been stable since monitoring began year 2000. has declined since the mid 90s but the figures are roughly Resistance mostly occurs to substances used in pig production. unchanged from year 2003. The sales of pleuromutilins for in- Hence, resistance to ampicillin, streptomycin, sulphonamides, feed or in-water medication of pigs has decreased by 39% over tetracycline or trimethoprim in E. coli and resistance to tetracy- the last five years. The decrease is probably explained by efforts cline or macrolides in enterococci are the most common traits. to contain swine dysentery. The use of macrolides has also In E. coli, resistance to third generation cephalosporins was not decreased by 31%, but the use of tetracyclines for in-feed or in- observed and quinolone resistance was rare. Vancomycin resist- water medication, adjusted for the lower dose of doxycycline ant enterococci were not isolated from pigs. In both E. coli and has increased by 21% since year 2000. These changes probably Enterococcus, there are indications of linked resistance genes. reflect a change in prescription pattern for treatment of respira- Resistance to some antimicrobials might therefore be a conse- tory infections in pigs. quence of co-selection whereby use of one antimicrobial selects The use of antimicrobials for dogs in year 2005 was esti- for resistance also to other substances. mated to 318 prescriptions/1000 dogs. Almost half (48%) Vancomycinresistant enterococci (VRE) were isolated on of the prescriptions were for cephalosporins or amoxicillin media supplemented with vancomycin, from 41 of 99 samples combined with clavulanic acid, and 14% were for fluoroqui- from chickens using. Since the start of monitoring year 2000, nolones. The
Recommended publications
  • The Diverse Search for Synthetic, Semisynthetic and Natural Product Antibiotics from the 1940S and up to 1960 Exemplified by a Small Pharmaceutical Player
    The Diverse Search for Synthetic, Semisynthetic and Natural Product Antibiotics From the 1940s and Up to 1960 Exemplified by a Small Pharmaceutical Player Leisner, Jørgen J. Published in: Frontiers in Microbiology DOI: 10.3389/fmicb.2020.00976 Publication date: 2020 Document version Publisher's PDF, also known as Version of record Document license: CC BY Citation for published version (APA): Leisner, J. J. (2020). The Diverse Search for Synthetic, Semisynthetic and Natural Product Antibiotics From the 1940s and Up to 1960 Exemplified by a Small Pharmaceutical Player. Frontiers in Microbiology, 11, [976]. https://doi.org/10.3389/fmicb.2020.00976 Download date: 29. Sep. 2021 fmicb-11-00976 June 10, 2020 Time: 21:55 # 1 REVIEW published: 12 June 2020 doi: 10.3389/fmicb.2020.00976 The Diverse Search for Synthetic, Semisynthetic and Natural Product Antibiotics From the 1940s and Up to 1960 Exemplified by a Small Pharmaceutical Player Jørgen J. Leisner* Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark The 1940s and 1950s witnessed a diverse search for not just natural product antibiotics but also for synthetic and semisynthetic compounds. This review revisits this epoch, using the research by a Danish pharmaceutical company, LEO Pharma, as an example. LEO adopted a strategy searching for synthetic antibiotics toward specific bacterial Edited by: Rustam Aminov, pathogens, in particular Mycobacterium tuberculosis, leading to the discovery of a University of Aberdeen, new derivative of a known drug. Work on penicillin during and after WWII lead to the United Kingdom development of associated salts/esters and a search for new natural product antibiotics.
    [Show full text]
  • Survey of Tiamulin+Oxytetracyclinein Control of CRD Complex Due to La Sota Vaccine in Broiler Chickens
    Available online a t www.scholarsresearchlibrary.com Scholars Research Library European Journal of Zoological Research, 2013, 2 (4): 45-49 (http://scholarsresearchlibrary.com/archive.html) ISSN: 2278–7356 Survey of Tiamulin+Oxytetracyclinein control of CRD complex due to La Sota vaccine in broiler chickens Adel Feizi Department of Clinical Sciences, Tabriz Branch, Islamic Azad University, Tabriz, Iran _____________________________________________________________________________________________ ABSTRACT Mycoplasma gallisepticum (MG) is one of the most important diseases of poultry industry in Iran and all over the world. Mortality, poor weight gain and increasing of feed conversion ratio (FCR) were seen in MG infected flocks. Several drugs are used for prevention and control of MG, the purpose of this study was to investigateoxytetracycline + Tiamulinefficacy on MG, and its role on broilers performance.In this study, 240 Ross 308 broilers divided in 2 groups. In one of the groups, oxytetracycline + Tiamulinwere used in days 21 to 30 following La Sota vaccination for controlling vaccination reaction and in the secondgroup, placebo was used and that group mentioned as a control group. Gross lesions, mortality, and growth parameters include body weight gain,feed intake and FCR were calculated in all groups weekly after 21 st day.Results showed that in treatment groups mortality percent was significantly (p<0.05) lower than control group and pericarditis, perihepatitis and airsacculitis was sever in control groups in comparison to antibiotic treated groups. Also body weight and FCR was significantly were different between control group and oxytetracycline + Tiamulin group (p<0.05).It can be concluded that usage of these antibiotics simultaneously could prevent vaccination reaction due to La Sota vaccine and also following MG complications, economical losses in poultry and finally it can be improve broilers performance Key words: Vaccination Reaction, Mycoplasma Gallisepticum, Oxytetracycline, Tiamulin, Ross 308.
    [Show full text]
  • Partners in Practice
    ADRENALS: Spring 2012 What you won’t find in a textbook Partners in Practice Dr Sue Foster BVSc, MVetClinStud, FACVSc Vetnostics Small Animal Medical Consultant ➤ Cutaneous Mycobacterial Disease in Dogs and Cats: Part 2 PART 4b: UCCr and CALP ➤ The Most Difficult and Frustrating Diagnoses As part 4 of this series looks at diagnostic tests, we can’t Corticosteroid-induced alkaline phosphatase escape some statistics. So, some very simplistic explanations (c-ALP) relative to hyperA are as follows: ➤ Adrenals: Part 4b Increased serum ALP, the most common routine laboratory Sensitivity: the likelihood that the test will detect hyperA abnormality in hyperA is due mainly to the induction Specificity: the chance that a positive test is truly hyperA of a specific ALP isoenzyme by glucocorticoids. The corticosteroid-induced isoenzyme of ALP can be measured Then, there are predictive values which take into account by electrophoretic separation, heat inactivation or more the prevalence or likelihood of a disease in addition to usually in commercial laboratories, by levamisole-inhibition. sensitivity and specificity. The levamisole inhibition explains why c-ALP is sometimes referred to as l-ALP but this terminology can be confusing Positive predictive value (PPV): the chance of a positive as sometimes l-ALP is used to describe the liver isoenzyme; result being indicative of hyperA in dogs with signs of it is also referred to as CAP (corticosteroid-induced ALP) or hyperA (e.g. Can we confidently diagnose hyperA when we SIAP (steroid-induced alkaline phosphatase). get a “positive” result?) The sensitivity of c-ALP has been reported to be 0.81-0.95.7-9 Negative predictive value (NPV): the likelihood that a Specificity is poor (0.18-0.44)7-9 and PPV in one study was negative results eliminates the possibility of hyperA in dogs as low as 21.4%7 thus this test cannot be recommended as with signs of hyperA (e.g.
    [Show full text]
  • Data on Before and After the Traceability System of Veterinary Antimicrobial Prescriptions in Small Animals at the University Veterinary Teaching Hospital of Naples
    animals Article Data on before and after the Traceability System of Veterinary Antimicrobial Prescriptions in Small Animals at the University Veterinary Teaching Hospital of Naples Claudia Chirollo , Francesca Paola Nocera , Diego Piantedosi, Gerardo Fatone , Giovanni Della Valle, Luisa De Martino * and Laura Cortese Department of Veterinary Medicine and Animal Productions, University of Naples, “Federico II”, Via Delpino 1, 80137 Naples, Italy; [email protected] (C.C.); [email protected] (F.P.N.); [email protected] (D.P.); [email protected] (G.F.); [email protected] (G.D.V.); [email protected] (L.C.) * Correspondence: [email protected]; Tel.: +39-081-253-6180 Simple Summary: Veterinary electronic prescription (VEP) is mandatory by law, dated 20 November 2017, No. 167 (European Law 2017) Article 3, and has been implemented in Italy since April 2019. In this study, the consumption of antimicrobials before and after the mandatory use of VEP was analyzed at the Italian University Veterinary Teaching Hospital of Naples in order to understand how the traceability of antimicrobials influences veterinary prescriptions. The applicability and utility of VEP may present an effective surveillance strategy able to limit both the improper use of Citation: Chirollo, C.; Nocera, F.P.; antimicrobials and the spread of multidrug-resistant pathogens, which have become a worrying Piantedosi, D.; Fatone, G.; Della Valle, threat both in veterinary and human medicine. G.; De Martino, L.; Cortese, L. Data on before and after the Traceability Abstract: Over recent decades, antimicrobial resistance has been considered one of the most relevant System of Veterinary Antimicrobial issues of public health.
    [Show full text]
  • NARMS – EB 2000 Veterinary Isolates Fig. 18. Resistance Among Salmonella Serotypes for Isolates from Cattle*
    NARMS – EB 2000 Veterinary Isolates Fig. 18. Resistance Among Salmonella Serotypes for Isolates from Cattle* S. typhimurium (n=332)** S. montevideo (n=330) Amikacin 0.00% Amikacin 0.00% Amox-Clav 14.46% Amox-Clav 0.61% Ampicillin 66.87% Ampicillin 0.61% Apramycin 1.20% Apramycin 0.00% Cefoxitin 10.54% Cefoxitin 0.61% Ceftiofur 12.65% Ceftiofur 0.61% Ceftriaxone 0.00% Ceftriaxone 0.00% Cephalothin 13.25% Cephalothin 0.61% Chloramphenicol 39.46% Chloramphenicol 0.91% Ciprofloxacin 0.00% Ciprofloxacin 0.00% Gentamicin 3.31% Gentamicin 0.30% Kanamycin 38.86% Kanamycin 0.00% Nalidixic Acid 0.00% Nalidixic Acid 0.00% Streptomycin 66.57% Streptomycin 1.52% Sulfamethoxazole 66.87% Sulfamethoxazole 1.21% Tetracycline 66.57% Tetracycline 2.12% Trimeth-Sulfa 5.42% Trimeth-Sulfa 0.30% 0% 10% 20% 30% 40% 50% 60% 70% 80% 0% 1% 1% 2% 2% 3% **including copenhagen S. anatum (n=292) S. newport (n=185) Amikacin 0.00% Amikacin 0.00% Amox-Clav 1.71% Amox-Clav 80.00% Ampicillin 2.40% Ampicillin 80.54% Apramycin 0.00% Apramycin 0.00% Cefoxitin 1.37% Cefoxitin 77.84% Ceftiofur 1.37% Ceftiofur 80.00% Ceftriaxone 0.00% Ceftriaxone 2.16% Cephalothin 2.05% Cephalothin 77.84% Chloramphenicol 1.71% Chloramphenicol 81.62% Ciprofloxacin 0.00% Ciprofloxacin 0.00% Gentamicin 0.68% Gentamicin 7.57% Kanamycin 1.71% Kanamycin 7.57% Nalidixic Acid 0.34% Nalidixic Acid 0.00% Streptomycin 2.05% Streptomycin 82.70% Sulfamethoxazole 2.05% Sulfamethoxazole 74.05% Tetracycline 35.96% Tetracycline 83.24% Trimeth-Sulfa 0.34% Trimeth-Sulfa 25.41% 0% 5% 10% 15% 20% 25% 30% 35% 40% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% *all sources NARMS – EB 2000 Veterinary Isolates Fig.
    [Show full text]
  • Simultaneous Determination of Amoxicillin and Clavulanic Acid in Pharmaceutical Preparations by Capillary Zone Electrophoresis
    Brazilian Journal of Pharmaceutical Sciences vol. 52, n. 2, apr./jun., 2016 Article http://dx.doi.org/10.1590/S1984-82502016000200006 Simultaneous determination of amoxicillin and clavulanic acid in pharmaceutical preparations by capillary zone electrophoresis Gabriel Hancu1,*, Anamaria Neacşu1, Lajos Attila Papp1, Adriana Ciurba2 1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Medicine and Pharmacy, TîrguMureş, Romania, 2Department of PharmaceuticalTechnology, Faculty of Pharmacy, University of Medicine and Pharmacy, Tîrgu Mureş, Romania Clavulanic acid enhances the antibacterial spectrum of amoxicillin by rendering most β-lactamase producing isolates susceptible to the drug. A fast, simple and efficient capillary electrophoresis method was developed for the simultaneous determination of amoxicillin and clavulanic acid from complex mixtures. Using a 25 mM sodium tetraborate as background electrolyte at a pH of 9.30, + 25 kV applied voltage, 25 °C system temperature, UV determination at 230 nm; we succeeded in simultaneous separation of amoxicillin and clavulanic acid in approximately 2 minutes. The analytical performance of the method was evaluated in terms of reproducibility, precision, accuracy, and linearity. The optimized analytical method was applied for the determination of the two analytes from combined commercial pharmaceutical preparations. This CE method is fast, inexpensive, efficient, and environmentally friendly when compared with the more frequently used high performance liquid chromatography methods described in the literature. Uniterms: Amoxicillin/determination. Clavulanic acid/determination. Capillary electrophoresis/ quantitative analysis. Antibacterials/quantitative analysis. O ácido clavulânico acentua o espectro antibacteriano de amoxicilina, tornando a maioria dos isolados produtores de β-lactamase sensíveis ao fármaco. Desenvolveu-se um método rápido, simples e eficiente de electroforese capilar (EC) para a determinação simultânea de amoxicilina e de ácido clavulânico a partir de misturas complexas.
    [Show full text]
  • Antibiotics Acting on the Translational Machinery
    Cell Science at a Glance 1391 Antibiotics acting on ribosomal factors, and recent structural Initiation studies of the ribosome (Ban et al., 2000; Prokaryotic protein synthesis starts with the translational Harms et al., 2001; Nissen et al., 2000; the formation of an initiation complex machinery Schlünzen et al., 2000; Wimberly et al., comprising the mRNA, initiator tRNA fMet 1, 1 2000; Yusupov et al., 2001) and (fMet-tRNA ), three initiation factors Jörg M. Harms *, Heike Bartels , complexes of ribosomes with inhibitors (IFs) and the 30S subunit. IF3 binding Frank Schlünzen1 and Ada (Brodersen et al., 2000; Pioletti et al., prevents association of the two Yonath1,2 2001; Schlünzen et al., 2001; Hansen et ribosomal subunits, verifies codon- 1Max-Planck Arbeitsgruppe Ribosomenstruktur, al., 2002; Bashan et al., 2003; Schlünzen anticodon complementarity and appears Notkestr. 85, 22607 Hamburg, Germany 2Department of Structural Biology, Weizmann et al., 2003) are now revealing the to regulate positioning of the mRNA. Institute, 76100 Rehovot, Israel mechanisms underlying their inhibitory IF1 blocks the acceptor site (A-site) to *Author for correspondence (e-mail: activity. prevent premature binding of the A-site [email protected]) tRNA. After binding of fMet-tRNAfMet, IF3 is released; this triggers hydrolysis Journal of Cell Science 116, 1391-1393 Responsibility for the various steps of © 2003 The Company of Biologists Ltd polypeptide synthesis is divided among of IF2-bound GTP, and IF2 and IF1 are doi:10.1242/jcs.00365 released (the exact sequence of events is the two ribosomal subunits (30S and not known). The 50S subunit then joins 50S). The 30S subunit ensures fidelity of Despite the appearance of bacterial the 30S initiation complex, forming the strains resistant to all clinical antibiotics, decoding by establishing accurate 70S ribosome.
    [Show full text]
  • Tetracycline and Sulfonamide Antibiotics in Soils: Presence, Fate and Environmental Risks
    processes Review Tetracycline and Sulfonamide Antibiotics in Soils: Presence, Fate and Environmental Risks Manuel Conde-Cid 1, Avelino Núñez-Delgado 2 , María José Fernández-Sanjurjo 2 , Esperanza Álvarez-Rodríguez 2, David Fernández-Calviño 1,* and Manuel Arias-Estévez 1 1 Soil Science and Agricultural Chemistry, Faculty Sciences, University Vigo, 32004 Ourense, Spain; [email protected] (M.C.-C.); [email protected] (M.A.-E.) 2 Department Soil Science and Agricultural Chemistry, Engineering Polytechnic School, University Santiago de Compostela, 27002 Lugo, Spain; [email protected] (A.N.-D.); [email protected] (M.J.F.-S.); [email protected] (E.Á.-R.) * Correspondence: [email protected] Received: 30 October 2020; Accepted: 13 November 2020; Published: 17 November 2020 Abstract: Veterinary antibiotics are widely used worldwide to treat and prevent infectious diseases, as well as (in countries where allowed) to promote growth and improve feeding efficiency of food-producing animals in livestock activities. Among the different antibiotic classes, tetracyclines and sulfonamides are two of the most used for veterinary proposals. Due to the fact that these compounds are poorly absorbed in the gut of animals, a significant proportion (up to ~90%) of them are excreted unchanged, thus reaching the environment mainly through the application of manures and slurries as fertilizers in agricultural fields. Once in the soil, antibiotics are subjected to a series of physicochemical and biological processes, which depend both on the antibiotic nature and soil characteristics. Adsorption/desorption to soil particles and degradation are the main processes that will affect the persistence, bioavailability, and environmental fate of these pollutants, thus determining their potential impacts and risks on human and ecological health.
    [Show full text]
  • Pharmacology
    FORM UPDATED | 04/07/20 Pharmacology 865-974-5646 Diagnostic Laboratory Service For lab Date Received: # of Samples Received: vetmed.tennessee.edu/vmc/dls use only Institution/Practice: ASSAYS CURRENTLY AVAILABLE Veterinarian: Aciclovir Gabapentin Address: Amoxicillin Galliprant Bromide Ganciclovir Bupivacaine Hydromorphone Butorphanol Itraconazole & Hydroxyitraconazole Carboplatin Ivermectin Phone: Caffeine Ketamine & Norketamine Fax: Carprofen Ketoprofen Carvedilol Lidocaine & metabolites Type of Sample: Ceftiofur Meloxicam No. of Samples: Ceftiofur Equivalents Midazolam & Hydroxmidazolam Cefovecin Metronidazole Date &Time Dosed: Chloramphenicol Moxidectin Citrate (urine only) Omeprazole Date & Time Collected: Deracoxib Oxalate (urine only) Dosage Amount: Diazepam and Nordiazepam Oxytetracycline Famciclovir/Penciclovir Piroxicam Dosage Formulation: Fenbendazole Praziquantil Route: Fentanyl Prednisolone Firocoxib Propofol Sample Identification Info: Flunixin Robenacoxib Species: Canine Feline Equine Fluconazole Terbinafine Other:__________________________________________________________ Fluoroquinolones: Thiafentanil Medication History (All medications the animal is currently on or has recently received): Ciprofloxacin Tramadol and metabolites Enrofloxacin M1, M2, M4, & M5 Fleroxacin Uric Acid Marbofloxacin Valciclovir Moxifloxacin Voriconazole Furosemide Requested Assay: If you are interested in drugs not listed, contact the laboratory with questions about assay development and cost. Ship Samples to: UTCVM Pharmacology Laboratory 2407
    [Show full text]
  • A Diverse Intrinsic Antibiotic Resistome from a Cave Bacterium
    ARTICLE Received 5 Jul 2016 | Accepted 1 Nov 2016 | Published 8 Dec 2016 DOI: 10.1038/ncomms13803 OPEN A diverse intrinsic antibiotic resistome from a cave bacterium Andrew C. Pawlowski1, Wenliang Wang1, Kalinka Koteva1, Hazel A. Barton2, Andrew G. McArthur1 & Gerard D. Wright1 Antibiotic resistance is ancient and widespread in environmental bacteria. These are there- fore reservoirs of resistance elements and reflective of the natural history of antibiotics and resistance. In a previous study, we discovered that multi-drug resistance is common in bacteria isolated from Lechuguilla Cave, an underground ecosystem that has been isolated from the surface for over 4 Myr. Here we use whole-genome sequencing, functional genomics and biochemical assays to reveal the intrinsic resistome of Paenibacillus sp. LC231, a cave bacterial isolate that is resistant to most clinically used antibiotics. We systematically link resistance phenotype to genotype and in doing so, identify 18 chromosomal resistance elements, including five determinants without characterized homologues and three mechanisms not previously shown to be involved in antibiotic resistance. A resistome comparison across related surface Paenibacillus affirms the conservation of resistance over millions of years and establishes the longevity of these genes in this genus. 1 Michael G. DeGroote Institute for Infectious Disease Research and the Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada L8S 4K1. 2 Department of Biology, University of Akron, Akron, Ohio 44325, USA. Correspondence and requests for materials should be addressed to G.D.W. (email: [email protected]). NATURE COMMUNICATIONS | 7:13803 | DOI: 10.1038/ncomms13803 | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms13803 nderstanding the evolution and origins of antibiotic rhizophila (formerly identified as Micrococcus luteus) resistance genes is vital to predicting, preventing and (Supplementary Tables 1 and 2).
    [Show full text]
  • A Sensitive Method for Direct Analysis of Impurities in Apramycin and Other Aminoglycoside Antibiotics Using Charged Aerosol
    - SO4 A Sensitive Method for Direct Analysis of Impurities in Apramycin and Other Aminoglycoside Antibiotics Using Charged Aerosol Detection Zhen Long1, Qi Zhang2, Yan Jin1, Lina Liang1, Bruce Bailey2, Ian Acworth2, Deepali Mohindra3 1 2 3 Thermo Fisher Scientific, Shanghai, China, Thermo Fisher Scientific, Chelmsford, MA, USA and Thermo Fisher Scientific, Sunnyvale, CA, USA Comparison of CAD and ELSD Detection Analysis of Other Aminoglycoside Antibiotics Overview Results Purpose: To develop a sensitive non-derivatization method for impurity assessment of Sample pre-treatment with SPE This method has also been applied to impurity analysis of an additional eleven apramycin sulfate and other aminoglycoside antibiotics. Sample pre-treatment with SPE SPE Column: Dionex OnGuard II A CAD and ELSD are both nebulization-based universal detection technologies. aminoglycoside antibiotics, including neomycin, gentamicin, kanamycin, streptomycin, Comparison between CAD and ELSD under the same chromatographic conditions tobramycin, amikacin, etimicin, netilmicin, sisomicin, ribostamycin and paromomycin. Methods: A 30min gradient method using hydrophilic interaction liquid chromatography Sample solvent: 80% 5mM ammonium formate, 20% acetonitrile Sulfate is a major interference for apramycin impurity assessment with a HILIC method. demonstrated that CAD is much more sensitive than ELSD. As shown in the Figure 5 shows impurity analysis of kenamycin, etimicin, ribostamycin and paromomycin with charged aerosol detection (HILIC-CAD) was developed for direct analysis of Sample: 220.6 mg/mL in 2 mL sample solvent Without sample cleanup, some early eluting impurities were found to be masked under chromatograms in Figure 4 and data summarized in Table 1, 16 impurities (S/N >3) were using the HILIC-CAD method.
    [Show full text]
  • Antibiotic Use Guidelines for Companion Animal Practice (2Nd Edition) Iii
    ii Antibiotic Use Guidelines for Companion Animal Practice (2nd edition) iii Antibiotic Use Guidelines for Companion Animal Practice, 2nd edition Publisher: Companion Animal Group, Danish Veterinary Association, Peter Bangs Vej 30, 2000 Frederiksberg Authors of the guidelines: Lisbeth Rem Jessen (University of Copenhagen) Peter Damborg (University of Copenhagen) Anette Spohr (Evidensia Faxe Animal Hospital) Sandra Goericke-Pesch (University of Veterinary Medicine, Hannover) Rebecca Langhorn (University of Copenhagen) Geoffrey Houser (University of Copenhagen) Jakob Willesen (University of Copenhagen) Mette Schjærff (University of Copenhagen) Thomas Eriksen (University of Copenhagen) Tina Møller Sørensen (University of Copenhagen) Vibeke Frøkjær Jensen (DTU-VET) Flemming Obling (Greve) Luca Guardabassi (University of Copenhagen) Reproduction of extracts from these guidelines is only permitted in accordance with the agreement between the Ministry of Education and Copy-Dan. Danish copyright law restricts all other use without written permission of the publisher. Exception is granted for short excerpts for review purposes. iv Foreword The first edition of the Antibiotic Use Guidelines for Companion Animal Practice was published in autumn of 2012. The aim of the guidelines was to prevent increased antibiotic resistance. A questionnaire circulated to Danish veterinarians in 2015 (Jessen et al., DVT 10, 2016) indicated that the guidelines were well received, and particularly that active users had followed the recommendations. Despite a positive reception and the results of this survey, the actual quantity of antibiotics used is probably a better indicator of the effect of the first guidelines. Chapter two of these updated guidelines therefore details the pattern of developments in antibiotic use, as reported in DANMAP 2016 (www.danmap.org).
    [Show full text]